The combined effects of apolipoprotein E polymorphism and low-density lipoprotein cholesterol on cognitive performance in young adults

Neuropsychobiology

Volumn 48, Issue 1, 2003, Pages 35-40

  Puttonen, Sampsa ^a   Elovainio, Marko ^a   Kivimäki, Mika ^a   Lehtimäki, Terho ^b,c   Keltikangas Järvinen, Liisa ^a  

^a UNIVERSITY OF HELSINKI   (Finland)

^b TAMPERE UNIVERSITY HOSPITAL   (Finland)

^c UNIVERSITY OF TAMPERE MEDICAL SCHOOL   (Finland)

Author keywords

Apolipoprotein E; Cognitive performance; Low density lipoprotein

Indexed keywords

APOLIPOPROTEIN E; LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ADULT; ARTICLE; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; COGNITION; CONTROLLED STUDY; DNA POLYMORPHISM; FEMALE; GENETIC ASSOCIATION; GENOTYPE; HUMAN; HUMAN EXPERIMENT; MALE; MENTAL TASK; MENTAL TEST; POPULATION RESEARCH; PRIORITY JOURNAL; REACTION TIME; TASK PERFORMANCE;

ADULT; ALLELES; APOLIPOPROTEINS E; CARDIOVASCULAR DISEASES; CHOICE BEHAVIOR; CHOLESTEROL, LDL; COGNITION; FEMALE; HUMANS; INTELLIGENCE TESTS; MALE; POLYMORPHISM, GENETIC; PROSPECTIVE STUDIES; RANDOM ALLOCATION; REACTION TIME; TIME FACTORS;

EID: 0042173187     PISSN: 0302282X     EISSN: None     Source Type: Journal    
DOI: 10.1159/000071827     Document Type: Article

References (36)

1. Mortimer BC, Redgrave TG, Spangler EA, Verstuyft JG, Rubin EM: Effect of human apoE4 on the clearance of chylomicron-like lipid emulsions and atherogenesis in transgenic mice. Arterioscler Thromb 1994;14:1542-1552.
2. Mahley RW, Rall SC Jr: Apolipoprotein E: Far more than a lipid transport protein. Annu Rev Genomics Hum Genet 2000;1:507-537.
3. Ravaja N, Räikkonen K, Lyytinen H, Lehtimäki T, Keltikangas-Järvinen L: Apolipoprotein E phenotypes and cardiovascular responses to experimentally induced mental stress in adolescent boys. J Behav Med 1997;20:571-587.
4. Stengård JH, Zerba KE, Pekkanen J, Ehnholm C, Nissinen A, Sing CF: Apolipoprotein E polymorphism predicts death from coronary heart disease in a longitudinal study of elderly Finnish men. Circulation 1995;91:265-269.
5. Staehelin HB, Perrig-Chiello P, Mitrache C, Miserez AR, Perrig WJ: Apolipoprotein E genotypes and cognitive functions in healthy elderly persons. Acta Neurol Scand 1999;100: 53-60.
6. Fillenbaum GG, Landerman LR, Blazer DG, Saunders AM, Harris TB, Launer LJ: The relationship of APOE genotype to cognitive functioning in older African-American and Caucasian community residents. J Am Geriatr Soc 2001;49:1148-1155.
7. Helkala EL, Koivisto K, Hänninen T, Vanhanen M, Kervinen K, Kuusisto J, Mykkänen L, Kesäniemi YA, Laakso M, Riekkinen P Sr: The association of apolipoprotein E polymorphism with memory: A population-based study. Neurosci Lett 1995;19:141-144.
8. Bondi MW, Salmon DP, Galasko D, Thomas RG, Thal LJ: Neuropsychological function and apolipoprotein E genotype in the preclinical detection of Alzheimer's disease. Psychol Aging 1999;14:295-303.
9. Parasuraman R, Greenwood PM, Sunderland T: The apolipoprotein E gene, attention, and brain function. Neuropsychology 2002;16: 254-274.
10. Mayeux R, Small SA, Tang M, Tycko B, Stern Y: Memory performance in healthy elderly without Alzheimer's disease: Effects of time and apolipoprotein-E. Neurobiol Aging 2001; 22:683-689.
11. Plassman BL, Welsh-Bohmer KA, Bigler ED, Johnson SC, Anderson CV, Helms MJ, Saunders AM, Breitner JC: Apolipoprotein E epsilon4 allele and hippocampal volume in twins with normal cognition. Neurology 1997;48: 985-989.
12. Small GW, Chen ST, Komo S, Ercoli L, Bookheimer S, Miller K, Lavretsky H, Saxena S, Kaplan A, Dorsey D, Scott WK, Saunders AM, Haines JL, Roses AD, Pericak-Vance MA: Memory self-appraisal in middle-aged and older adults with the apolipoprotein E-4 allele. Am J Psychiatry 1999;156:1035-1038.
13. Smith GE, Bohac DL, Waring SC, Kokmen E, Tangalos EG, Ivnik RJ, Petersen RC: Apolipoprotein E genotype influences cognitive 'phenotype' in patients with Alzheimer's disease but not in healthy control subjects. Neurology 1998;50:355-362.
14. Small BJ, Graves AB, McEvoy CL, Crawford FC, Mullan M, Mortimer JA: Is APOE-epsilon4 a risk factor for cognitive impairment in normal aging? Neurology 2000;54:2082-2088.
15. Collie A, Maruff P, Shafiq-Antonacci R, Smith M, Hallup M, Schofield PR, Masters CL, Currie J: Memory decline in healthy older people: Implications for identifying mild cognitive impairment. Neurology 2001;56:1533-1538.
16. Hubacek JA, Pitha J, Skodova Z, Adamkova V, Lanska V, Poledne R: A possible role of apolipoprotein E polymorphism in predisposition to higher education. Neuropsychobiology 2001; 43:200-203.
17. Barres BA, Smith S J: Cholesterol - Making or breaking the synapse. Science 2002;294:1296-1297.
18. Horsten M, Wamala SP, Vingerhoets A, Orth-Gomer K: Depressive symptoms, social support, and lipid profile in healthy middle-aged women. Psychosom Med 1997;59:521-528.
19. Freedman DS, Byers T, Barrett DH, Stroup NE, Eaker E, Monroe-Blum H: Plasma lipid levels and psychological characteristics in men. Am J Epidemiol 1995;141:507-517.
20. Terao T, Iwata N, Kanazawa K, Takano T, Takahashi N, Hayashi T, Sugawara Y: Low serum cholesterol levels and depressive state in human dock visitors. Acta Psychiatr Scand 2000;101:231-234.
21. Strandberg T.E., Räikkonen K., Partinen M, Pihl S, Vanhanen H, Miettinen TA, Associations of cholesterol lowering by statins with anger and hostility in hypercholesterolemic men. Biol Psychiatry 1994;35:575-577.
22. Coutu MF, Dupuis G, D'Antono B: The impact of cholesterol lowering on patients' mood. J Behav Med 2001;24:517-536.
23. Muldoon MF, Ryan CM, Matthews KA, Manuck SB: Serum cholesterol and intellectual performance. Psychosom Med 1997;59:382-387.
24. Kivipelto M, Helkala EL, Laakso MP, Hänninen T, Hallikainen M, Alhainen K, Soininen H, Tuomilehto J, Nissinen A: Midlife vascular risk factors and Alzheimer's disease in later life: Longitudinal, population-based study. BMJ 2001;322:1447-1451.
25. Ordovas JM, Schaefer EJ: Genes, variation of cholesterol and fat intake and serun lipids. Curr Opin Lipidol 1999;10:15-22.
26. Kraemer HC, Stice E, Kazdin A, Offord D, Kupfer D: How do risk factors work together? Mediators, moderators, and independent, overlapping, and proxy risk factors. Am J Psychiatry 2001;158:848-856.
27. Åkerblom H K, Uhari M, Pesonen E, Dahl M, Kaprio EA, Nuutinen EM, Pietikäinen M, Salo MK, Aromaa A, Kannas L, Keltikangas-Järvinen L, Kuusela V, Räsänen L, Rönnemaa T, Knip M, Telama R, Välimäki I, Pyörälä K, Viikari J: Cardiovascular risk in young Finns. Ann Med 1991;23:35-40.
28. Keltikangas-Järvinen L, Räikkönen K, Lehtimäki T: Dependence between apolipoprotein E phenotypes and temperament in children, adolescents, and young adults. Psychosom Med 1993;55:155-156.
29. Cacioppo J, Malarkey W, Kiecolt-Glacer J, Uchino B, Sgoutas-Emch S, Sheridan J, Berntson G, Glaser R: Heterogeneity in neuroendocrine and immune responses to brief psychological stressors as a function of autonomic cardiac activation. Psychosom Med 1995;57:154-164.
30. Cohen J, Cohen P: Applied Multiple Regression/Correlation Analysis for the Behavioral Sciences, ed 2. Hillsdale, Erlbaum, 1983.
31. Deloche G, Hannequin D, Carlomagno S, Agniel A, Dordain M, Pasquier F, Pellat J, Denis P, Desi M, Beauchamp D: Calculation and number processing in mild Alzheimer's disease. J Clin Exp Neuropsychol 1995;17: 634-639.
32. Rosselli M, Ardila A, Arvizu L, Kretzmer T, Standish V, Liebermann J: Arithmetical abilities in Alzheimer disease. Int J Neurosci 1998; 96:141-148.
33. Wechsler D: Wechsler Memory Scale - Revised. New York, Psychological Corporation, 1986.
34. Kivipelto M, Helkala EL, Hänninen T, Laakso MP, Hallikainen M, Alhainen K, Soininen H, Tuomilehto J, Nissinen A: Midlife vascular risk factors and late-life mild cognitive impairment: A population-based study. Neurology 2001;56:1683-1689.
35. Helbecque N, Berr C, Cottel D, Fromentin-David I, Sazdovitch V, Ricolfi F, Ducimetière P, Di Menza C, Amouyel P: VLDL receptor polymorphism, cognitive impairment, and dementia. Neurology 2001;56:1183-1188.
36. Smith U: Life style and genes-the key factors for diabetes and the metabolic syndrome. J Intern Med 1992;232:99-101.